Radiofrequency ablation of hepatocellular carcinoma extended into the portal vein: Preliminary results

Journal of Ultrasound

Volumn 12, Issue 1, 2009, Pages 32-37

  Giorgio, A ^a   de Stefano, G ^a   Di Sarno, A ^a   Farella, N ^a   Giorgio, V ^a   Scognamiglio, U ^a   Mariniello, A ^a   Liorre, G ^a   Perrotta, A ^a   Mariniello, N ^a  

^a AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Portal vein; Tumor thrombus

Indexed keywords

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER INVASION; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; MALE; NEEDLE BIOPSY; PERCUTANEOUS THROMBECTOMY; PORTAL VEIN; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECANALIZATION; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR NECROSIS; TUMOR THROMBUS;

EID: 61649098142     PISSN: 19713495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jus.2008.12.004     Document Type: Article

References (21)

1. Stuart K.E., Anand A.J., and Jenkins R.L. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 77 (1996) 2217-2222
2. Llovet J.M., Bustamante J., Castells A., Vilana R., Ayuso Mdel C., Sala M., et al. Natural history of untreated non surgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 29 (1999) 62-67
3. Villa E., Moles A., Ferretti I., Buttafoco P., Grottola A., Del Buono M., et al. Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival. Hepatology 32 (2000) 535-539
4. Masami M., and Makuuchi M. Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol 21 47 (2006) 7561-7567
5. Rossi S., Garbagnati F., Lencioni R., Allgaier H.P., Marchianò A., Fornari F., et al. Percutaneous radiofrequency thermal ablation of non resectable hepatocellular carcinoma after occlusion of tumor blood therapy. Radiology 217 1 (2000) 119-126
6. Livraghi T., Goldberg S.N., Lazzaroni S., Meloni F., Ierace T., Solbiati L., et al. Hepatocellular carcinoma: radiofrequency ablation of medium end large lesions. Radiology 214 3 (2000) 761-768
7. Seror O., N'Kontcho G., Ibraheem M., Ajavon Y., Barrucand C., Ganne N., et al. Large (> or =5 cm) HCCs: multipolar RF ablation with three internally coded bipolar electrodes: initial experience in 26 patients. Radiology 248 1 (2008) 288-296
8. Giorgio A., Tarantino L., de Stefano G., Perrotta A., Aloisio V., del Viscovo L., et al. Ultrasound-guided percutaneous ethanol injection under general anaesthesia for the treatment of hepatocellular carcinoma on cirrhosis: long-term results in 268 patients. Eur J Ultrasound 12 2 (2000) 145-154
9. Giorgio A., Ferraioli G., Tarantino L., de Stefano G., Scala V., Scarano F., et al. Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance. AJR Am J Roentgenol 183 (2004) 1319-1326
10. Gaiani S., Celli N., Piscaglia F., Cecilioni L., Losinno F., Giangregorio F., et al. Usefulness of contrast enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol 41 3 (2004 Sep) 421-426
11. Giorgio A., De Stefano G., Coppola C., Ferraioli G., Esposito V., Di Sarno A., et al. Contrast-enhanced sonography in the characterization of small hepatocellular carcinomas in cirrhotic patients: comparison with contrast enhanced ultrafast magnetic resonance imaging. Anticancer Res 27 (2007) 4263-4270
12. Giorgio A., Tarantino L., de Stefano G., Scala V., Liorre G., Scarano F., et al. Percutaneous sonographically guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma. AJR Am J Roentgenol 181 2 (2003) 479-484
13. Obi S., Yoshida H., Toune R., Unuma T., Kanda M., Sato S., et al. Combination therapy of intraarterial 5 fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion. Cancer 106 9 (2006) 1990-1997
14. Chen X.P., Qiu F.Z., Wu Z.D., Zhang Z.W., Huang Z.Y., Chen Y.F., et al. Effects of location and extension of portal vein tumor thrombus on long term outcomes of surgical treatment for hepatocellular carcinoma. Ann Surg Oncol 13 7 (2006) 940-946
15. Konishi M., Ryu M., Kinoshita T., and Inoue K. Surgical treatment of hepatocellular carcinoma with direct removal of the tumor thrombus in the main portal vein. Hepatogastroenterology 41 (2001) 1421-1424
16. Pawlik T.M., Poon R.T., Abdalla E.K., Ikai I., Nagorney D.M., Belghiti J., et al. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery 137 4 (2005) 403-410
17. Ikai I., Yamamoto Y., Yamamoto N., Terajima H., Hatano E., Shimahara Y., et al. Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins. Surg Oncol Clin N Am 12 1 (2003) 65-75
18. Le Treut Y.P., Hardwigsen J., Ananian P., Saïsse J., Grégoire E., Richa H., et al. Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series. J Gastrointest Surg 10 6 (2006) 855-862
19. Bruix J., Sherman M., Llovet J.M., Beaugrand M., Lencioni R., Burroughs A.K., et al. Clinical management of hepatocellular carcinoma. Conclusion of the Barcelona-2000 EASL-Conference. J Hepatol 35 (2001) 421-430
20. Bruix J., and Sherman M. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236
21. Livraghi T., Grigioni W., Mazziotti A., Sangalli G., and Vettori C. Percutaneous alcohol injection of portal thrombosis in hepatocellular carcinoma: a new possible treatment. Tumori 76 4 (1990 Aug 31) 394-397